Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004160691 | SCV003649083 | uncertain significance | not specified | 2022-09-22 | criteria provided, single submitter | clinical testing | The c.20609T>C (p.L6870P) alteration is located in exon 19 (coding exon 19) of the FSIP2 gene. This alteration results from a T to C substitution at nucleotide position 20609, causing the leucine (L) at amino acid position 6870 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |